{"transactions":[{"id":3928350,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2018-05-17T21:18:27.000Z","date":"2018-05-15","kind":"purchase","acquired":true,"shares":200,"price":6.45,"value":1290.0,"ownership":{"direct":false,"nature":"By Daughter."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares."}],"balance_after":1450,"source":{"system":"sec-edgar","filing":"0001437749-18-010288","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774918010288/rdgdoc.xml","form_type":"4"}},{"id":3928349,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2018-05-17T21:18:27.000Z","date":"2018-05-15","kind":"purchase","acquired":true,"shares":200,"price":6.45,"value":1290.0,"ownership":{"direct":false,"nature":"By Daughter."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares."}],"balance_after":1450,"source":{"system":"sec-edgar","filing":"0001437749-18-010288","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774918010288/rdgdoc.xml","form_type":"4"}},{"id":3928348,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2018-05-17T21:18:27.000Z","date":"2018-05-15","kind":"purchase","acquired":true,"shares":2000,"price":6.4455,"value":12891.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Held jointly with spouse."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001437749-18-010288","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774918010288/rdgdoc.xml","form_type":"4"}},{"id":3928347,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2018-05-17T21:18:27.000Z","date":"2018-05-15","kind":"purchase","acquired":true,"shares":5500,"price":6.4455,"value":35450.25,"ownership":{"direct":true},"balance_after":35500,"source":{"system":"sec-edgar","filing":"0001437749-18-010288","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774918010288/rdgdoc.xml","form_type":"4"}},{"id":4086659,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T18:56:45.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on January 25, 2019 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":5.5,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-18-001305","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774918001305/rdgdoc.xml","form_type":"4"}},{"id":4149093,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-11-29T16:24:42.000Z","date":"2017-11-29","kind":"gift","acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Daughter."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001437749-17-019919","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917019919/rdgdoc.xml","form_type":"4"}},{"id":4149092,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-11-29T16:24:42.000Z","date":"2017-11-29","kind":"gift","acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Daughter."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account."}],"balance_after":1250,"source":{"system":"sec-edgar","filing":"0001437749-17-019919","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917019919/rdgdoc.xml","form_type":"4"}},{"id":4149091,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-11-29T16:24:42.000Z","date":"2017-11-29","kind":"gift","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001437749-17-019919","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917019919/rdgdoc.xml","form_type":"4"}},{"id":4149090,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-11-29T16:24:42.000Z","date":"2017-11-27","kind":"purchase","acquired":true,"shares":2055,"price":3.85,"value":7911.75,"ownership":{"direct":true},"balance_after":32500,"source":{"system":"sec-edgar","filing":"0001437749-17-019919","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917019919/rdgdoc.xml","form_type":"4"}},{"id":4149089,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-11-29T16:24:42.000Z","date":"2017-11-27","kind":"purchase","acquired":true,"shares":2990,"price":3.8,"value":11362.0,"ownership":{"direct":true},"balance_after":30445,"source":{"system":"sec-edgar","filing":"0001437749-17-019919","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917019919/rdgdoc.xml","form_type":"4"}},{"id":4149088,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-11-29T16:24:42.000Z","date":"2017-11-27","kind":"purchase","acquired":true,"shares":1310,"price":3.75,"value":4912.5,"ownership":{"direct":true},"balance_after":27455,"source":{"system":"sec-edgar","filing":"0001437749-17-019919","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917019919/rdgdoc.xml","form_type":"4"}},{"id":4149087,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-11-29T16:24:42.000Z","date":"2017-11-27","kind":"purchase","acquired":true,"shares":1145,"price":3.7,"value":4236.5,"ownership":{"direct":true},"balance_after":26145,"source":{"system":"sec-edgar","filing":"0001437749-17-019919","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917019919/rdgdoc.xml","form_type":"4"}},{"id":4224541,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-08-25T16:32:22.000Z","date":"2017-08-24","kind":"purchase","acquired":true,"shares":5000,"price":2.5764,"value":12882.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001437749-17-015335","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917015335/rdgdoc.xml","form_type":"4"}},{"id":4303081,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-05-26T16:05:01.000Z","date":"2017-05-25","kind":"purchase","acquired":true,"shares":526,"price":4.1449,"value":2180.2174,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-17-010179","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917010179/rdgdoc.xml","form_type":"4"}},{"id":4303080,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-05-26T16:05:01.000Z","date":"2017-05-25","kind":"purchase","acquired":true,"shares":1974,"price":4.1,"value":8093.4,"ownership":{"direct":true},"balance_after":19474,"source":{"system":"sec-edgar","filing":"0001437749-17-010179","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917010179/rdgdoc.xml","form_type":"4"}},{"id":4367027,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-03-31T16:24:44.000Z","date":"2017-03-31","kind":"purchase","acquired":true,"shares":1000,"price":4.7,"value":4700.0,"ownership":{"direct":true},"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001437749-17-005785","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917005785/rdgdoc.xml","form_type":"4"}},{"id":4367026,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Common Stock","published_at":"2017-03-31T16:24:44.000Z","date":"2017-03-29","kind":"purchase","acquired":true,"shares":1500,"price":4.3347,"value":6502.05,"ownership":{"direct":true},"balance_after":16500,"source":{"system":"sec-edgar","filing":"0001437749-17-005785","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917005785/rdgdoc.xml","form_type":"4"}},{"id":4475403,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt. & Public Relations"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-31T17:06:39.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the \"Plan\"). 25% of the shares will vest on January 27, 2018 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":3.55,"expiration_date":"2027-01-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-17-001395","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774917001395/rdgdoc.xml","form_type":"4"}},{"id":4535400,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Govt and Public Relations"}}],"security":"Common Stock","published_at":"2016-12-02T09:00:51.000Z","date":"2016-11-30","kind":"purchase","acquired":true,"shares":4253,"price":3.5,"value":14885.5,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001562180-16-003645","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000156218016003645/primarydocument.xml","form_type":"4"}},{"id":4535399,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Govt and Public Relations"}}],"security":"Common Stock","published_at":"2016-12-02T09:00:51.000Z","date":"2016-11-30","kind":"purchase","acquired":true,"shares":747,"price":3.475,"value":2595.825,"ownership":{"direct":true},"balance_after":10747,"source":{"system":"sec-edgar","filing":"0001562180-16-003645","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000156218016003645/primarydocument.xml","form_type":"4"}},{"id":4609456,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt and Public Relations"}}],"security":"Common Stock","published_at":"2016-09-07T16:22:14.000Z","date":"2016-09-06","kind":"purchase","acquired":true,"shares":3690,"price":5.011,"value":18490.59,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-16-038425","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774916038425/rdgdoc.xml","form_type":"4"}},{"id":4609455,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt and Public Relations"}}],"security":"Common Stock","published_at":"2016-09-07T16:22:14.000Z","date":"2016-09-02","kind":"purchase","acquired":true,"shares":1000,"price":4.5999,"value":4599.9,"ownership":{"direct":true},"balance_after":6310,"source":{"system":"sec-edgar","filing":"0001437749-16-038425","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774916038425/rdgdoc.xml","form_type":"4"}},{"id":4609454,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt and Public Relations"}}],"security":"Common Stock","published_at":"2016-09-07T16:22:14.000Z","date":"2016-09-02","kind":"purchase","acquired":true,"shares":2000,"price":4.5939,"value":9187.8,"ownership":{"direct":true},"balance_after":5310,"source":{"system":"sec-edgar","filing":"0001437749-16-038425","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774916038425/rdgdoc.xml","form_type":"4"}},{"id":4609453,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt and Public Relations"}}],"security":"Common Stock","published_at":"2016-09-07T16:22:14.000Z","date":"2016-09-02","kind":"purchase","acquired":true,"shares":2000,"price":4.5899,"value":9179.8,"ownership":{"direct":true},"balance_after":3310,"source":{"system":"sec-edgar","filing":"0001437749-16-038425","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774916038425/rdgdoc.xml","form_type":"4"}},{"id":4609452,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":166570,"kind":"person","name":"Cohen Daniel L","position":1,"cik":"0001672300","reported_name":"Cohen Daniel L","relationship":{"officer":true,"officer_title":"EVP, Govt and Public Relations"}}],"security":"Common Stock","published_at":"2016-09-07T16:22:14.000Z","date":"2016-09-02","kind":"purchase","acquired":true,"shares":1310,"price":4.5899,"value":6012.769,"ownership":{"direct":true},"balance_after":1310,"source":{"system":"sec-edgar","filing":"0001437749-16-038425","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672300/000143774916038425/rdgdoc.xml","form_type":"4"}}]}